Position in VTRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,053
+$2,124 QoQ
Shares Held
885
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#738
of 1,016 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Coston, McIsaac & Partners holds $48,181 across 6 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (29.2% of the industry book) .
All Filings in VTRS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,053 | 885 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $11,929 | 883 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $10,968 | 881 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $9,464 | 956 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $8,501 | 952 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $10,199 | 1,171 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $14,504 | 1,165 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $18,018 | 1,552 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $17,326 | 1,630 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $23,151 | 1,939 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $21,075 | 1,946 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $19,088 | 1,936 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,950 | 1,999 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $19,134 | 1,989 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $20,991 | 1,886 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $15,992 | 1,877 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $19,547 | 1,867 | Shares | Sole | 2022-09-21 | |
| No filing history on record for this holder in this stock. | ||||||